Abstract
Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) Score Predicts Long-term Clinical Disease Activity (CDA)-free Status and Disability Progression in Subcutaneous Interferon Beta-1a (scifnβ-1a)-treated Patients
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have